Emergent BioSolutions (EBS) Assets Average (2011 - 2026)

Emergent BioSolutions has reported Assets Average for 16 years, with the latest figure at $1.2 billion in Q2 2026.

• On a quarterly basis, Assets Average fell 14.28% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 14.28% decrease from a year earlier, with the FY2025 full-year figure at $1.4 billion, down 15.71% from the prior year.
• Assets Average was $1.2 billion for Q2 2026 at Emergent BioSolutions, down from $1.3 billion in the prior quarter.
• The five-year high for Assets Average was $3.1 billion in Q1 2023, with the low at $1.2 billion in Q2 2026.
• Average Assets Average over 5 years is $2.0 billion, with a median of $1.7 billion recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Assets Average grew 6.59% in 2023, then tumbled 40.7% in 2024.
• Over 5 years, Assets Average stood at $3.0 billion in 2022, then sank by 38.7% to $1.9 billion in 2023, then declined by 22.84% to $1.4 billion in 2024, then slipped by 3.07% to $1.4 billion in 2025, then decreased by 12.32% to $1.2 billion in 2026.
• The last three Assets Average figures came in at $1.2 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.